Industry News

Canon Medical to Develop Rapid Genetic Testing System for Novel Coronavirus (COVID-19)

This project is part of a research program focusing on the development of diagnostic methods for COVID-19.

Author Image

By: Anthony Locicero

Copy editor, New York Post

Canon U.S.A., Inc. announced that Canon Medical Systems Corporation (Canon Medical) started the development of a rapid genetic testing system for the novel coronavirus (COVID-19). This project is part of a research program focusing on the development of diagnostic methods for COVID-19 led by the Japan Agency for Medical Research. Canon Medical was selected to participate in this research program in cooperation with Nagasaki University. This was in recognition of Canon Medical’s strength ...

Continue reading this story and get 24/7 access to Ink World magazine for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters